Response rate and molecular correlates to encorafenib and binimetinib in BRAF-V600E mutant high-grade glioma. Schreck KC, Strowd RE, Nabors LB, Ellingson BM, et al. Clin Cancer Res 2024 Mar 6. doi: 10.1158/1078-0432.CCR-23-3241.

Read + Share

Amedeo Smart

Independent Medical Education

Schreck KC, Strowd RE, Nabors LB, Ellingson BM, et al. Response rate and molecular correlates to encorafenib and binimetinib in BRAF-V600E mutant high-grade glioma. Clin Cancer Res 2024 Mar 6. doi: 10.1158/1078-0432.CCR-23-3241.
PMID: 38446982